A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
Article in European Urology Oncology (January 2024)
The most recent citing publications are shown below. View all 51 publications that cite this research output on Dimensions.
Article in European Urology Oncology (January 2024)
Article in Synlett (September 2023)
Article in Clinical and Translational Radiation Oncology (July 2022)